According to the latest report by IMARC Group, titled “Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global drug-eluting stents market reached a value of US$ 7.3 Billion in 2021. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 10.8 Billion by 2027, growing at a CAGR of 6.50% during 2022-2027.
Drug-eluting stents refer to coronary or peripheral tools that are widely used in the treatment of blockage of heart arteries. These stents are generally placed within the coronary or peripheral artery by an interventional radiologist or cardiologist during an angioplasty procedure. They are small mesh tubes that are generally manufactured using metal or polymers and coated with slow-release medication that is inserted into an artery for preventing the formation of scar tissues in arterial walls. As a result, they ensure adequate blood flow to the body while minimizing the chance of restenosis.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/drug-eluting-stents-market/requestsample
Market Trends:
The global market is primarily driven by the rising prevalence of coronary heart diseases among the masses. This is supported by the sedentary lifestyle patterns and unhealthy dietary habits of individuals. Since drug-eluting stents are minimally invasive in nature, facilitate fast vessel healing and reduce the need for prolonged dual antiplatelet therapy, this is providing a boost to the market growth. Additionally, continual product innovations, such as the utilization of antiproliferative drugs in the stent in order to reduce the chance of in-stent restenosis, are gaining widespread prominence.
In line with this, the introduction of drug-eluting stents manufactured using bioabsorbable polymers due to an enhanced focus on sustainable development is creating a positive outlook for the market. Moreover, increasing investments by private and public agencies in upgrading the existing healthcare infrastructure are also propelling the market growth. Other factors, including the rising geriatric population, the growing healthcare expenditure, and extensive research and development (R&D) activities conducted by key players, are further contributing to the market growth.
Key Market Segmentation:
Competitive Landscape:
- Abbott Laboratories
- Braun Melsungen AG
- Biosensors International Group Ltd
- Biotronik
- Boston Scientific Corporation
- Cardinal Health Inc
- Cook Medical LLC (Cook Group Incorporated)
- Lepu Medical Technology (Beijing) Co. Ltd
- Medtronic plc
- MicroPort Scientific Corporation
- Sino Medical Sciences Technology Inc
- Terumo Corporation
Based On Coating:
- Polymer Based Coating
- Polymer Free Coating
Based On Drug:
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Others
Based On Stent Platform:
- Stainless-steel
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Others
Based On Generation:
- 1st Generation
- 2nd Generation
- 3rd Generation
- 4th Generation
Based On Application:
- Coronary Artery Disease
- Peripheral Artery Disease
Based On End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Based On Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Click here to view detailed information with table of content: https://www.imarcgroup.com/drug-eluting-stents-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Trending Reports (Book Now with 10% Discount + COVID-19 Scenario):
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com/
